Aiko Kato1, Osamu Okamoto2, Weimin Wu1, Noritaka Matsuo3, Jun Kumai4, Yuji Yamada4, Fumihiko Katagiri4, Motoyoshi Nomizu4, Sakuhei Fujiwara5. 1. Department of Plastic Surgery, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 879-5593, Japan. 2. Department of Dermatology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 879-5593, Japan. Electronic address: ookamoto@oita-u.ac.jp. 3. Department of Biochemistry, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 879-5593, Japan. 4. Laboratory of Clinical Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan. 5. Department of Dermatology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 879-5593, Japan.
Abstract
BACKGROUND: Dermatopontin (DP) is a 22kDa acidic extracellular matrix (ECM) protein that plays a critical role in both ECM structure and wound healing. Previously, we demonstrated that DP interacts with fibronectin (Fn) and promotes formation of insoluble Fn fibrils that are called activated Fn (Kato et al., J Biol Chem 2011;286:14861-9). OBJECTIVE: Details of the interaction between DP and Fn are investigated to further examine the biological functions of DP. METHODS: Interactive sites between Fn and DP were examined by a solid-phase assay using Fn, DP, and their respective recombinant proteins and synthetic peptides. The effect of the DP peptides on insoluble Fn fibril formation was examined by both electrophoresis and electron microscopy. RESULTS: A binding site in DP for Fn was identified as the DP-4 (PHGQVVVAVRS) peptide, and the major binding site in Fn for DP was the 14th type III repeat (III14) domain. Further, the major DP binding site in the III14 domain was located around the B- and C-strands and their connecting loop region. A synthetic cyclic peptide mimicking the Fn loop structure enhanced DP binding activity. The DP-4 peptide induced Fn polymerization but the morphology was different from that of Fn fibrils formed by full length DP. The Fn fibrils with DP-4 enhanced integrin α5β1-mediated cell adhesion and spreading. CONCLUSION: Interactive sites between Fn and DP were identified. The DP-4 peptide activated Fn and enhanced cell adhesion activity. DP-4 has the potential to be used for therapeutic applications, such as a wound treatment.
BACKGROUND:Dermatopontin (DP) is a 22kDa acidic extracellular matrix (ECM) protein that plays a critical role in both ECM structure and wound healing. Previously, we demonstrated that DP interacts with fibronectin (Fn) and promotes formation of insoluble Fn fibrils that are called activated Fn (Kato et al., J Biol Chem 2011;286:14861-9). OBJECTIVE: Details of the interaction between DP and Fn are investigated to further examine the biological functions of DP. METHODS: Interactive sites between Fn and DP were examined by a solid-phase assay using Fn, DP, and their respective recombinant proteins and synthetic peptides. The effect of the DP peptides on insoluble Fn fibril formation was examined by both electrophoresis and electron microscopy. RESULTS: A binding site in DP for Fn was identified as the DP-4 (PHGQVVVAVRS) peptide, and the major binding site in Fn for DP was the 14th type III repeat (III14) domain. Further, the major DP binding site in the III14 domain was located around the B- and C-strands and their connecting loop region. A synthetic cyclic peptide mimicking the Fn loop structure enhanced DP binding activity. The DP-4 peptide induced Fn polymerization but the morphology was different from that of Fn fibrils formed by full length DP. The Fn fibrils with DP-4 enhanced integrin α5β1-mediated cell adhesion and spreading. CONCLUSION: Interactive sites between Fn and DP were identified. The DP-4 peptide activated Fn and enhanced cell adhesion activity. DP-4 has the potential to be used for therapeutic applications, such as a wound treatment.
Authors: Sven Francque; Gyongyi Szabo; Manal F Abdelmalek; Christopher D Byrne; Kenneth Cusi; Jean-François Dufour; Michael Roden; Frank Sacks; Frank Tacke Journal: Nat Rev Gastroenterol Hepatol Date: 2020-10-22 Impact factor: 46.802
Authors: Philippe Lefebvre; Fanny Lalloyer; Eric Baugé; Michal Pawlak; Céline Gheeraert; Hélène Dehondt; Jonathan Vanhoutte; Eloise Woitrain; Nathalie Hennuyer; Claire Mazuy; Marie Bobowski-Gérard; Francesco Paolo Zummo; Bruno Derudas; Ann Driessen; Guy Hubens; Luisa Vonghia; Wilhelmus J Kwanten; Peter Michielsen; Thomas Vanwolleghem; Jérôme Eeckhoute; An Verrijken; Luc Van Gaal; Sven Francque; Bart Staels Journal: JCI Insight Date: 2017-07-06
Authors: Petra Popovics; Asha Jain; Kegan O Skalitzky; Elise Schroeder; Hannah Ruetten; Mark Cadena; Kristen S Uchtmann; Chad M Vezina; William A Ricke Journal: Int J Mol Sci Date: 2021-11-18 Impact factor: 5.923
Authors: Xabier Unamuno; Javier Gómez-Ambrosi; Beatriz Ramírez; Amaia Rodríguez; Sara Becerril; Víctor Valentí; Rafael Moncada; Camilo Silva; Javier Salvador; Gema Frühbeck; Victoria Catalán Journal: J Clin Med Date: 2020-04-09 Impact factor: 4.241